Zobrazeno 1 - 10
of 193
pro vyhledávání: '"Anido Herranz U"'
Autor:
Ferreiro-Pantín, M., Anido-Herranz, U., Betancor, Y.Z., Cebey-López, V., León-Mateos, L., García-González, J., García-Acuña, S.M., Fernández-Díaz, N., Tubio, J.M.C., López-López, R., Ruiz-Bañobre, J.
Publikováno v:
In ESMO Open August 2023 8(4)
Autor:
Ruiz-Bañobre, J., Molina-Díaz, A., Fernández-Calvo, O., Fernández-Núñez, N., Medina-Colmenero, A., Santomé, L., Lázaro-Quintela, M., Mateos-González, M., García-Cid, N., López-López, R., Vázquez, S., Anido-Herranz, U.
Publikováno v:
In ESMO Open April 2021 6(2)
Autor:
Fernández Calvo O; Department of Medical Oncology, Complexo Hospitalario Universitario de Ourense, Ourense, Spain. ovidiofernandezcalvo@yahoo.es., Muñoz Iglesias J; Department of Nuclear Medicine (SERGAS), University Hospital of Vigo, Meixoeiro Hospital, Vigo, Spain., Abou Jokh Casas E; Department of Nuclear Medicine, Hospital Universitario Lucus Augusti, Lugo, Spain., Molina-Díaz A; Department of Medical Oncology, Complexo Hospitalario Universitario de A Coruña, A Coruña, Spain., Anido Herranz U; Department of Medical Oncology, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain., Casas Nebra J; Uro-Oncology Unit, Complexo Hospitalario Universitario de A Coruña, A Coruña, Spain., García-Bernardo L; Department of Nuclear Medicine, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain., Martínez-Breijo S; Department of Urology, Complexo Hospitalario Universitario de A Coruña, A Coruña, Spain., Lázaro-Quintela M; Department of Medical Oncology, University Hospital of Vigo, Meixoeiro Hospital, Vigo, Spain., Muñiz-García G; Department of Nuclear Medicine, Complexo Hospitalario Universitario de Ourense, Ourense, Spain., Vázquez-Estevez S; Department of Medical Oncology, Hospital Universitario Lucus Augusti de Lugo, Lugo, Spain.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Sep 12. Date of Electronic Publication: 2024 Sep 12.
Autor:
Anido-Herranz U; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain., Fernandez-Calvo O; Department of Medical Oncology, University Clinical Hospital of Ourense, Ourense, Spain., Ruiz-Bañobre J; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Martinez-Breijo S; Department of Urology, University Clinical Hospital of A Coruña, A Coruña, Spain., Fernandez-Nuñez N; Department of Medical Oncology, Lucus Augusti University Hospital, Lugo, Spain., Nogareda-Seoane Z; Department of Nuclear Medicine, University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, Spain., Garrido-Pumar M; Department of Nuclear Medicine, University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, Spain., Casas-Nebra J; Department of Urology, Lucus Augusti University Hospital, Lugo, Spain., Muñiz-Garcia G; Department of Nuclear Medicine - GALARIA, Complexo Hospitalario Universitario Ourense A. S. de Ourense, Ourense, Spain., Portela-Pereira P; Department of Urology, Area Sanitaria de Ourense, Ourense, Spain., Gomez-Caamaño A; Department of Radiation Oncology, University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, Spain., Perez-Fentes DA; Department of Urology, EOXI University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, Spain., Santome-Couto L; Department of Medical Oncology, POVISA, Vigo, Spain., Lázaro M; Department of Medical Oncology, Álvaro Cunqueiro Hospital, Vigo, Spain., Molina-Diaz A; Department of Medical Oncology, University Clinical Hospital of A Coruña, A Coruña, Spain., Medina-Colmenero A; Department of Medical Oncology, Fundación Centro Oncológico de Galicia, A Coruña, Spain., Vazquez-Estevez S; Department of Medical Oncology, Lucus Augusti University Hospital, Lugo, Spain.
Publikováno v:
Frontiers in oncology [Front Oncol] 2024 May 07; Vol. 14, pp. 1385466. Date of Electronic Publication: 2024 May 07 (Print Publication: 2024).
Autor:
Betancor YZ; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain., Ferreiro-Pantín M; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain., Anido-Herranz U; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain., Fuentes-Losada M; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain., León-Mateos L; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., García-Acuña SM; Department of Pathology, University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain., Vaamonde-Rodríguez V; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain., García-Pinel B; Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain., Cebey-López V; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain., Villaverde-Viaño R; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain., Lombardía-Rodríguez H; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain., Kotrulev M; Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain., Fernández-Díaz N; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain., Gomez-Tourino I; Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain., Fernández-Baltar C; Department of Urology, Complexo Hospitalario Universitario de Pontevedra, Pontevedra, Spain., García-González J; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Tubio JMC; Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain., López-López R; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Ruiz-Bañobre J; Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago de Compostela, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Department of Medical Oncology, University Clinical Hospital of Santiago de Compostela (SERGAS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Apr 10; Vol. 15, pp. 1374728. Date of Electronic Publication: 2024 Apr 10 (Print Publication: 2024).
Autor:
Juan Fita MJ; Fundación Instituto Valenciano de Oncología, Carrer del Professor Beltrán Báguena, 8, 46009 Valencia, Spain., Anido Herranz U; Medical Oncology, Complejo Hospitalario Universitario de Santiago, 15706 Santiago de Compostela, Spain., Mendez-Vidal MJ; Medical Oncology, Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), Hospital Universitario Reina Sofía (HURS), 14004 Córdoba, Spain., Gironés-Sarrió R; Medical Oncology, Hospital Universitari i Politècnic la Fe, 46026 Valencia, Spain., Muñoz-Langa J; Medical Oncology, Hospital Arnau de Vilanova, 46015 Valencia, Spain., Sepúlveda-Sánchez J; Medical Oncology, Hospital Universitario 12 de Octubre, Instituto de Investigación 12 de Octubre, 28041 Madrid, Spain., Mellado B; Medical Oncology, Hospital Clinic of Barcelona, 08036 Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain., Alvarez-Fernandez C; Medical Oncology, Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias, 33011 Oviedo, Spain., Heras López L; Servicio de Oncología Médica, Unidad de Sarcomas, Melanoma y Genitourinario, Institut Català d'Oncologia, 08908 L'Hospitalet de Llobregat, Spain., López-Guerrero JA; Laboratory of Molecuar Biology, Fundación Instituto Valenciano de Oncología, 46009 Valencia, Spain.; Department of Pathology, Catholic University of València, 46001 Valencia, Spain., García-Casado Z; Laboratory of Molecuar Biology, Fundación Instituto Valenciano de Oncología, 46009 Valencia, Spain., Calatrava A; Servicio Anatomía Patológica, Fundación Instituto Valenciano de Oncología, 46009 Valencia, Spain., Ángel Climent M; Fundación Instituto Valenciano de Oncología, Carrer del Professor Beltrán Báguena, 8, 46009 Valencia, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Oct 31; Vol. 15 (21). Date of Electronic Publication: 2023 Oct 31.
Autor:
Paez, D., Lecumberri, A., Soria Rivas, A., Leon Mateos, L.A., García-Martinez, H., Anido Herranz, U., Castanon Lopez, C., Elez Fernandez, M.E., Fernandez-Rañada Shaw, I., Iglesias Docampo, L.C.
Publikováno v:
In Annals of Oncology September 2024 35 Supplement 2:S952-S952
Autor:
Hernando Cubero, J., Martinez Lago, N., Mitjavila, M., Garcia-Burillo, A., Pubul, V., Bello, P., Cano, J.M., Llana, B., Castellón, M., Rodeño, E., Piñeiro, A., Soldevilla, C., Nevares, M., Aller, J., Anido Herranz, U., Carnero Lopez, B., Nogareda, Z., Garcia Alvarez, A., Jimenez Fonseca, P., Capdevila Castillon, J.
Publikováno v:
In Annals of Oncology September 2024 35 Supplement 2:S756-S756
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Anido Herranz, U., Fernandez-Diaz, N., Garcia-Gonzalez, J., Cebey-Lopez, V., Z. Betancor, Y., Ferreiro-Pantin, M., Fuentes-Losada, M., Touris-Lores, M., Vaamonde-Rodriguez, V., Villaverda-Viano, R., Bernandez-Ferran, B., Blanco-Parra, M., Lopez-Lopez, R., Ruiz-Banobre, J.
Publikováno v:
In European Urology Open Science November 2023 57 Supplement 1:S233-S233